Myosin binding protein C: structural abnormalities in familial hypertrophic cardiomyopathy.

Cecily E Oakley, Brett D. Hambly, Paul M.G. Curmi, Louise Brown

    Research output: Contribution to journalArticlepeer-review

    48 Citations (Scopus)


    The muscle protein myosin binding protein C (MyBPC) is a large multi-domain protein whose role in the sarcomere is complex and not yet fully understood. Mutations in MyBPC are strongly associated with the heart disease familial hypertrophic cardiomyopathy (FHC) and these experiments of nature have provided some insight into the intricate workings of this protein in the heart. While some regions of the MyBPC molecule have been assigned a function in the regulation of muscle contraction, the interaction of other regions with various parts of the myosin molecule and the sarcomeric proteins, actin and titin, remain obscure. In addition, several intra-domain interactions between adjacent MyBPC molecules have been identified. Although the basic structure of the molecule (a series of immunoglobulin and fibronectin domains) has been elucidated, the assembly of MyBPC in the sarcomere is a topic for debate. By analysing the MyBPC sequence with respect to FHC-causing mutations it is possible to identify individual residues or regions of each domain that may be important either for binding or regulation. This review looks at the current literature, in concert with alignments and the structural models of MyBPC, in an attempt to understand how FHC mutations may lead to the disease state.

    Original languageEnglish
    Pages (from-to)95-110
    Number of pages16
    JournalCell research
    Issue number2
    Publication statusPublished - 2004


    Dive into the research topics of 'Myosin binding protein C: structural abnormalities in familial hypertrophic cardiomyopathy.'. Together they form a unique fingerprint.

    Cite this